WOLFGANG WINKELMAYER to Hyperlipidemias
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Hyperlipidemias.
Connection Strength
0.289
-
Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020 04 06; 10(1):5964.
Score: 0.153
-
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study. Appl Health Econ Health Policy. 2015 Apr; 13(2):193-205.
Score: 0.108
-
Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):90-9.
Score: 0.028